论文信息 - Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma - 字舞流文

Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

H. Goldschmidt | A. Glasmacher | H. Nückel | I. Schmidt-Wolf | T. Moehler | R. Naumann | T. G. S. Group | C. Scheid | M. Gorschlueter | U. Platzbecker | W. Knauf | H. Salwender | K. Weisel | I. Blau | M. Hänel | T. Geer | Britta Auel | M. Gorschlüter